The Indian Institute of Science (IISc) on Monday announced that it would set up a Postgraduate Medical School along with an 800-bed multi-speciality hospital in its Bengaluru campus based on the......
'The main reason for the deaths is trust.' K Kesavan, an advocate and joint secretary of the Centre for Protection of Civil Liberties, has moved a Public Interest Litigation in the Madras high......
Banaras Hindu University, Institute of Medical SciencesAdmission Notice for MD/MS-2004An entrance test on an all India basis will be held on April 4, 2004 at Varanasi for admission to MD/MS courses......
Medical PG Programmes at CMC, VelloreChristian Medical College, Vellore invites applications for admission to the following Medical Postgraduate Programmes: 1. Diploma in Child Health/Obstetrics &......
Swarnajayanti Fellowships 2003 The Governmentof Indiainstitutedthe Swarnajayanti Fellowships to commemoratethe 50th year of India's Independence. Under the scheme a selected number of young......
Tele/video-consults have been effective for patients requiring post-hospitalisation follow-up, especially if they are from outside the city; patients with chronic diseases that need periodic......
While companies continue to face regulatory pressure leading to higher costs, they see an uptick from the launch of differentiated and high-margin products. Illustration: Uttam Ghosh/Rediff.com......
Trouble-hit Ranbaxy Laboratories has introduced a whistle-blower policy within the company to encourage transparency and address concerns internally, so that bigger problems could be averted.In his......
India's biggest drug maker, Ranbaxy, has acquired Biovel Lifesciences, a Bangalore-based biotech company making typhoid and influenza vaccines, for an undisclosed sum. With this, Ranbaxy would make......
The leading Indian drug maker, Ranbaxy has acquired the rights from Bristol-Myers Squibb to manufacture and market 13 dermatology brands in the United States for $25 million. This is Ranbaxy's......